Finch Therapeutics Group, Inc. - FNCH
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | History | No change | 59,028 | 155 | 0.0% | 0.0% | 1 | 0 | 0.0% | Q1 2024 | May 07, 2024 |
| VANGUARD GROUP INC | History | Reduced | 36,252 | 94 | 0.0% | 0.0% | 2 | -2,512 | -6.48% | Q1 2024 | May 10, 2024 |
| Tower Research Capital LLC (TRC) | History | Added to | 4,163 | 10 | 0.0% | 0.0% | 3 | +1,537 | 58.53% | Q1 2024 | May 15, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -11,746 | -100.0% | Q4 2023 | Feb 13, 2024 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | History | Closed out | 0 | 0 | — | — | — | -141 | -100.0% | Q4 2023 | Feb 13, 2024 |
| UBS Group AG | History | Added to | 110 | 0 | — | — | — | +108 | 5400.0% | Q1 2024 | May 13, 2024 |
| MORGAN STANLEY | History | Added to | 156 | 0 | — | — | — | +33 | 26.83% | Q1 2024 | Oct 17, 2024 |
| BANK OF AMERICA CORP /DE/ | History | Closed out | 0 | 0 | — | — | — | -12 | -100.0% | Q4 2023 | Feb 14, 2024 |
| WELLS FARGO & COMPANY/MN | History | Added to | 7 | 0 | — | — | — | +1 | 16.67% | Q1 2024 | May 10, 2024 |
| ROYAL BANK OF CANADA | History | No change | 27 | 0 | — | — | — | 0 | 0.0% | Q1 2024 | Nov 05, 2024 |